The effects of in utero exposure to teratogens on organ size: a prospective paediatric study

J J A De Smidt1, H J Odendaal2, D G Nel3

  • 1Department of Medical Biosciences, University of the Western Cape, Cape Town, South Africa.

Insights

Maternal smoking during pregnancy was linked to smaller kidney and pancreas sizes in children at age 5 in a low-income population. This in utero teratogen exposure may impact long-term health and cardiometabolic risk.

Area of Science:

  • Pediatric Health
  • Environmental Health
  • Developmental Biology

Background:

  • Prospective data on combined in utero teratogen exposure effects are scarce in low-income countries.
  • Understanding these effects is crucial for early health interventions and risk assessment.

Purpose of the Study:

  • To investigate the impact of in utero teratogen exposure, specifically maternal smoking and alcohol consumption, on kidney and pancreas size at 5 years of age.
  • To establish ultrasound reference values for pediatric kidney and pancreas measurements in a low-income setting.

Main Methods:

  • A cohort of 500 mother-child pairs from a low-income setting was studied.
  • Ultrasound measurements of kidney and pancreas size were taken at age 5.
  • Anthropometric and clinical data, including maternal factors, were collected and analyzed using multiple regression.

Main Results:

  • Children exposed in utero to maternal smoking had significantly smaller left and right kidney lengths and pancreas body measurements at age 5.
  • Waist circumference showed a significant association with pancreas head and tail measurements, influenced by in utero exposure, sex, and BMI.

Conclusions:

  • In utero exposure to nicotine (maternal smoking) negatively affects kidney and pancreas size in children by age 5.
  • These organ size differences may contribute to future cardiometabolic risk.
  • The study provides valuable ultrasound reference data for this pediatric population.

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
94
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.7K